BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15455386)

  • 1. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors.
    Hammouda D; Muñoz N; Herrero R; Arslan A; Bouhadef A; Oublil M; Djedeat B; Fontanière B; Snijders P; Meijer C; Franceschi S
    Int J Cancer; 2005 Jan; 113(3):483-9. PubMed ID: 15455386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.
    Franceschi S; Rajkumar T; Vaccarella S; Gajalakshmi V; Sharmila A; Snijders PJ; Muñoz N; Meijer CJ; Herrero R
    Int J Cancer; 2003 Oct; 107(1):127-33. PubMed ID: 12925967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
    Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
    Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP; Li N; Smith JS; Qiao YL
    Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors.
    Illades-Aguiar B; Cortés-Malagón EM; Antonio-Véjar V; Zamudio-López N; Alarcón-Romero Ldel C; Fernández-Tilapa G; Hernández-Sotelo D; Terán-Porcayo MA; Flores-Alfaro E; Leyva-Vázquez MA
    Cancer Detect Prev; 2009; 32(4):300-7. PubMed ID: 19022588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
    Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
    Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR).
    Yamakawa Y; Forslund O; Teshima H; Hasumi K; Kitagawa T; Hansson BG
    Gynecol Oncol; 1994 May; 53(2):190-5. PubMed ID: 8188078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.
    Muñoz N; Franceschi S; Bosetti C; Moreno V; Herrero R; Smith JS; Shah KV; Meijer CJ; Bosch FX;
    Lancet; 2002 Mar; 359(9312):1093-101. PubMed ID: 11943256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus infection in a population-based sample of women in Algiers, Algeria.
    Hammouda D; Clifford GM; Pallardy S; Ayyach G; Chékiri A; Boudrich A; Snijders PJ; van Kemenade FJ; Meijer CJ; Bouhadef A; Zitouni Z; Habib D; Ikezaren N; Franceschi S
    Int J Cancer; 2011 May; 128(9):2224-9. PubMed ID: 20607828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
    Tay SK; Oon LL
    Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.
    Castellsagué X; Díaz M; Vaccarella S; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Meijer CJ; Bosch FX
    Lancet Oncol; 2011 Oct; 12(11):1023-31. PubMed ID: 21917519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection and invasive cervical cancer in Paraguay.
    Rolón PA; Smith JS; Muñoz N; Klug SJ; Herrero R; Bosch X; Llamosas F; Meijer CJ; Walboomers JM
    Int J Cancer; 2000 Feb; 85(4):486-91. PubMed ID: 10699919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
    Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.
    Kasamatsu E; Cubilla AL; Alemany L; Chaux A; Tous S; Mendoza L; Paez M; Klaustermeier JE; Quint W; Lloveras B; de Sanjose S; Muñoz N; Bosch FX
    J Med Virol; 2012 Oct; 84(10):1628-35. PubMed ID: 22930512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.